SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-010236
Filing Date
2022-03-15
Accepted
2022-03-15 08:35:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A evok-defa14a_20220427.htm DEFA14A 21181
2 GRAPHIC gjkbgokgab5q000002.jpg GRAPHIC 341457
3 GRAPHIC gjkbgokgab5q000001.jpg GRAPHIC 652090
  Complete submission text file 0001564590-22-010236.txt   1390641
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36075 | Film No.: 22739237
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences